MAPS Wants to Turn MDMA Into a Prescription Medicine [VIDEO]
MAPS - the Multidisciplinary Association for Psychedelic Studies - has been conducting DEA and FDA approved clinical trials using MDMA in conjunction with psychotherapy to treat Post Traumatic Stress Disorder in veterans, survivors of abuse and sexual assault, and victims of violent crime.
While most folks in the electronic music scene know it as the chemical that's supposed to be in "ecstasy" pills or "molly" powder, MDMA had a history of therapeutic use long before it became a party drug. As it gained popularity in the nightlife scene the DEA (over)reacted by adding it to Schedule One, thereby banning it not only from recreational use, but also making medical research all but impossible. MAPS has been fighting to reverse this decision, and gain FDA approval to turn MDMA into a prescription medicine. They have helped fund multiple clinical trials around the world, working with a variety of trauma survivors with severe PTSD.
The preliminary results of their phase 1 and phase 2 trials have been incredibly promising:
Preliminary results from this study are showing that 56% of participants receiving MDMA-assisted psychotherapy experienced clinically significant (30% or more) decreases in PTSD symptoms two months after treatment, compared with only 17% of those receiving placebo. These results are even stronger one year after treatment, with 80% of participants experiencing significant improvements. This preliminary data reaffirms the promising results of our study published in 2011, which found that 83% of participants no longer had PTSD two months after treatment.
Check out the video below, and if you would like to donate to support their work, head over to MAPS.org